Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending June 14, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the Company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is strictly a regulatory notification of share transactions and does not contain financial performance data.
Material Changes
The filing details specific share transfers from the GlaxoSmithKline Employee Trust ("GSK Trust") to participants in the SmithKline Beecham Employee Share Option Plan 1991:
- June 9, 2006: 8,830 Ordinary Shares transferred.
- June 12, 2006: 11,280 Ordinary Shares transferred.
Three directors (Dr J-P Garnier, Dr M M Slaoui, and Mr J S Heslop) are noted as having an interest in the shares held in the GSK Trust in the same capacity as other employees.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the disclosure of the aforementioned share transactions in accordance with Disclosure Rule 3.1.4R(1)(b).
Key Facts for Investor Verification
- Verify the total number of shares transferred from the GSK Trust to the Employee Share Option Plan (1991) during the reporting period.
- Confirm the specific dates of the transactions (June 9 and June 12, 2006) and the notification dates to the Company.
- Review the status of the GSK Trust as a discretionary trust for current and former employees.
- Note that this filing does not contain financial results; investors should refer to Form 20-F for financial data.